These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29653781)
1. Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey. Vicini E; Invento A; Cuoghi M; Bafile A; Battaglia C; Biglia N; Busani M; Bussone R; Cianchetti E; Caruso F; Cucchi MC; Dessena M; Di Filippo F; Fabi N; Folli S; Friedman D; Macellari G; Mainente P; Murgo R; Neri A; Pollini GP; Palli D; Ricci F; Scalco G; Taffurelli M; Trunfio M; Galimberti V; Eur J Surg Oncol; 2018 Aug; 44(8):1157-1163. PubMed ID: 29653781 [TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
3. Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network" (SICO-CCN) multicentre collaborative study. Degiuli M; Arolfo S; Evangelista A; Lorenzon L; Reddavid R; Staudacher C; De Nardi P; Rosati R; Elmore U; Coco C; Rizzo G; Belluco C; Forlin M; Milone M; De Palma GD; Rega D; Delrio P; Guerrieri M; Ortenzi M; Muratore A; Marsanic P; Restivo A; Deidda S; Zuin M; Pucciarelli S; De Luca R; Persiani R; Biondi A; Roviello F; Marrelli D; Sgroi G; Turati L; Morino M Eur J Surg Oncol; 2018 Aug; 44(8):1233-1240. PubMed ID: 29705284 [TBL] [Abstract][Full Text] [Related]
4. The Italian Society of Surgical Oncology (SICO) survey on the minimum requirements of rare cancers referral centers. Gronchi A; Delrio P; Quagliuolo V; Sandrucci S Updates Surg; 2016 Dec; 68(4):321-323. PubMed ID: 27312931 [No Abstract] [Full Text] [Related]
5. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres. van Dam PA; Tomatis M; Marotti L; Heil J; Mansel RE; Rosselli Del Turco M; van Dam PJ; Casella D; Bassani LG; Danei M; Denk A; Egle D; Emons G; Friedrichs K; Harbeck N; Kiechle M; Kimmig R; Koehler U; Kuemmel S; Maass N; Mayr C; Prové A; Rageth C; Regolo L; Lorenz-Salehi F; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Audisio R; Ponti A; Eur J Cancer; 2017 Nov; 85():15-22. PubMed ID: 28881247 [TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
7. How Can We Improve Education of Breast Surgeons Across Europe? Kolacinska A Chirurgia (Bucur); 2017; 112(4):365-366. PubMed ID: 28862111 [TBL] [Abstract][Full Text] [Related]
8. [Breast cancer care quality analysis of the National Institute of Oncology in Hungary according to the requirements of European Society of Breast Cancer Specialists (EUSOMA)]. Újhelyi M; Pukancsik D; Kelemen P; Sávolt Á; Gődény M; Kovács E; Udvarhelyi N; Bak M; Polgár C; Rubovszky G; Kásler M; Mátrai Z Orv Hetil; 2016 Oct; 157(42):1674-1682. PubMed ID: 27748131 [TBL] [Abstract][Full Text] [Related]
9. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey. Caballero C; Lundon DJ; Vasileva-Slaveva M; Montagna G; Bonci EA; Brandl A; Smith H; Kok JHH; Holmberg CJ; Sayyed R; Santrac N; Suppan I; Kaul P; Vassos N; Lorenzon L; Murphy M; Ceelen W; de Azambuja E; McIntosh SA; Rubio IT Eur J Surg Oncol; 2024 Oct; 50(10):108585. PubMed ID: 39146663 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer. Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517 [TBL] [Abstract][Full Text] [Related]
11. The multicenter experience in the multidisciplinary Italian breast units: a review and update. Magnoni F; Tinterri C; Corso G; Curigliano G; Leonardi MC; Toesca A; Rocco N; Catalano F; Bianchi B; Lauria F; Caldarella P; Pagani G; Galimberti V; Veronesi P Eur J Cancer Prev; 2024 May; 33(3):185-191. PubMed ID: 37997909 [TBL] [Abstract][Full Text] [Related]
12. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Biganzoli L; Wildiers H; Oakman C; Marotti L; Loibl S; Kunkler I; Reed M; Ciatto S; Voogd AC; Brain E; Cutuli B; Terret C; Gosney M; Aapro M; Audisio R Lancet Oncol; 2012 Apr; 13(4):e148-60. PubMed ID: 22469125 [TBL] [Abstract][Full Text] [Related]
13. Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis. Kiderlen M; Ponti A; Tomatis M; Boelens PG; Bastiaannet E; Wilson R; van de Velde CJ; Audisio RA; Eur J Cancer; 2015 Jul; 51(10):1221-30. PubMed ID: 25892645 [TBL] [Abstract][Full Text] [Related]
14. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312 [TBL] [Abstract][Full Text] [Related]
15. New challenges in multimodal workout of locally advanced breast cancer. Sanchez AM; Franceschini G; Orlandi A; Di Leone A; Masetti R Surgeon; 2017 Dec; 15(6):372-378. PubMed ID: 28624359 [TBL] [Abstract][Full Text] [Related]
16. Surgical Outcomes for Mastectomy Patients Receiving Neoadjuvant Chemotherapy: A Propensity-Matched Analysis. Bowen ME; Mone MC; Buys SS; Sheng X; Nelson EW Ann Surg; 2017 Mar; 265(3):448-456. PubMed ID: 27280515 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy in stage III breast cancer. Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927 [TBL] [Abstract][Full Text] [Related]
18. The effect of EUSOMA certification on quality of breast cancer care. van Dam PA; Tomatis M; Marotti L; Heil J; Wilson R; Rosselli Del Turco M; Mayr C; Costa A; Danei M; Denk A; Emons G; Friedrichs K; Harbeck N; Kiechle M; Koheler U; Kuemmel S; Maass N; Marth C; Prové A; Kimmig R; Rageth C; Regolo L; Salehi L; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Ponti A; ; Eur J Surg Oncol; 2015 Oct; 41(10):1423-9. PubMed ID: 26278019 [TBL] [Abstract][Full Text] [Related]
19. Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy. Yalcin B Exp Oncol; 2013 Dec; 35(4):250-2. PubMed ID: 24382433 [TBL] [Abstract][Full Text] [Related]
20. [Audit system on quality of breast cancer diagnosis and treatment: results of quality indicators on screen-detected lesions in Italy, 2010]. Ponti A; Mano MP; Tomatis M; Baiocchi D; Barca A; Berti R; Bisanti L; Casella D; Deandrea S; Delrio D; Donati G; Falcini F; Frammartino B; Frigerio A; Mantellini P; Naldoni C; Orzalesi L; Pagano G; Pietribiasi F; Ravaioli A; Sedda ML; Taffurelli M; Cataliotti L; Segnan N Epidemiol Prev; 2012; 36(6 Suppl 1):87-95. PubMed ID: 23293273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]